BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Proneuron Biotechnologies Ltd. (Israel - Headquarters) 

P.O. Box 277

Ness-Ziona    74101  Israel
Phone: 972-8-9409550 Fax: 972-8-9409560


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Weizmann Institute of Science  Rehovot, Israel - Research and Development

Sheba Medical Center  Tel Hashomer, Israel - Clinical Trials, Research and Development

Rabin Medical Center (Beilinson Hospital)  Petach Tikva, Israel - Clinical Trials

Erasme Hospital  Brussels, Belgium - Clinical Trials





 Company News
Proneuron Biotechnologies, Inc.'s ProCord Granted European Patent 10/19/2005 5:13:06 PM    More...
Proneuron Biotechnologies, Inc. (US Branch) Announces Milestone Patent For Copolymer-1 -- Cop-1; Patent Expands Use Of Cop-1, Previously Approved For The Treatment Of MS 10/19/2005 5:12:44 PM    More...
Proneuron Biotechnologies, Inc. (US Branch)'s Phase II Experimental ProCord Procedure For Complete Spinal Cord Injury Now Available At The Mount Sinai Medical Center In NY & University Hospital In Collaboration With Kessler Institute For Rehabilitation In NJ 10/19/2005 5:12:23 PM    More...
Shriners Hospitals For Children, Philadelphia Now Enrolling For Proneuron Biotechnologies, Inc. (US Branch)'s Phase II ProCord Study 10/19/2005 5:12:14 PM    More...
The Mount Sinai Medical Center And Kessler Institute For Rehabilitation Are Now Enrolling For Proneuron's Phase II Study Of ProCord For Neurologically Complete Spinal Cord Injury 10/19/2005 5:11:40 PM    More...
Proneuron Biotechnologies, Inc. (US Branch) And Cell Design Of Atlanta To Establish A New Cell Processing Facility In Atlanta To Support The Current Phase II Trial Of ProCord For Complete Spinal Cord Injury 10/19/2005 5:11:37 PM    More...
Shepherd Center And Proneuron Biotechnologies, Inc. (US Branch) Receive $3.2 Million Commitment From The For Phase II Study Of ProCord, An Experimental Procedure For Acute Spinal Cord Injury 10/19/2005 5:10:21 PM    More...
Proneuron Biotechnologies, Inc. (US Branch) Welcomes Dr. Marca L. Sipski To The Company's ProCord Study Steering Committee Guiding The Phase II Study Of ProCord For Complete Spinal Cord Injury 10/19/2005 5:10:19 PM    More...
Proneuron Biotechnologies Ltd. (Israel)'s ProCord Receives FDA Orphan Drug Designation 10/19/2005 5:10:08 PM    More...
Victory Found In Journey: Pool Accident Leads Lifeguard To Unproven Therapy, Change In Outlook On Life 10/19/2005 5:09:21 PM    More...
12